There were no significant differences in plasma orexin A concentrations of COVID-19 patients suffering from cardiovascular disease, respiratory disease, or obesity (Supplementary Fig. S2A–C). This evidence concerns the gene HCRT and obesity due to melanocortin 4 receptor deficiency.